Bim is a pro‐apoptotic Bcl‐2 family member of the BH3‐only protein subgroup. Expression levels of Bim determine apoptosis susceptibility in non‐malignant and in tumour cells. Bim protein expression is downregulated by proteasomal degradation following ERK‐dependent phosphorylation and ubiquitination. Here, we report the identification of a deubiquitinase, Usp27x, that binds Bim upon its ERK‐dependent phosphorylation and can upregulate its expression levels. Overexpression of Usp27x reduces ERK‐dependent Bim ubiquitination, stabilizes phosphorylated Bim, and induces apoptosis in PMA‐stimulated cells, as well as in tumour cells with a constitutively active Raf/ERK pathway. Loss of endogenous Usp27x enhances the Bim‐degrading activity of oncogenic Raf. Overexpression of Usp27x induces low levels of apoptosis in melanoma and non‐small cell lung cancer (NSCLC) cells and substantially enhances apoptosis induced in these cells by the inhibition of ERK signalling. Finally, deletion of Usp27x reduces apoptosis in NSCLC cells treated with an EGFR inhibitor. Thus, Usp27x can trigger via its proteolytic activity the deubiquitination of Bim and enhance its levels, counteracting the anti‐apoptotic effects of ERK activity, and therefore acts as a tumour suppressor. Synopsis This study shows that the deubiquitinase Usp27x binds to the pro‐apoptotic BH3‐only protein Bim and counter‐regulates Bim degradation through the Raf/ERK pathway. Levels of Usp27x determine the apoptotic outcome and might be relevant for the treatment response in such cells. The deubiquitinase Usp27x binds to phosphorylated Bim and stabilizes Bim by deubiquitination, counteracting Bim degradation by ERK. Loss of endogenous Usp27x enhances the Bim‐degrading activity of oncogenic Raf. Overexpression of Usp27x enhances apoptosis in cancer cells with a constitutively active Raf/ERK pathway; therefore, Usp27x may act as a tumour suppressor. This study shows that the deubiquitinase Usp27x binds to the pro‐apoptotic BH3‐only protein Bim and counter‐regulates Bim degradation through the Raf/ERK pathway. Levels of Usp27x determine the apoptotic outcome and might be relevant for the treatment response in such cells.